Abstracts are now being accepted for the upcoming Geothermal Rising Conference taking place in Reno, Nevada on 26-29 October ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...

Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...

The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...

Students and judges interact during the 70th annual Mid-Columbia Regional Science and Engineering Fair held this year at the ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

Late-breaking clinical and first translational data from BOND-003 Cohort C will be presentedIRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical ...

The 11th International Granulation Workshop will be held in 2025. The workshop consists of two parts: a 2-day hands-on Course ...

Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...

Kamitsos, researcher and former director of the Theoretical and Physical Chemistry Institute (TPCI), National Hellenic ...